Institutional investors purchased a net $725.2 thousand shares of PBYI during the quarter ended December 2012. This may signal that the smart money is gaining interest in this company as the 74.10% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
| Other institutional | 42.66% |
| Individual stakeholders | 32.92% |
| Mutual fund holders | 31.43% |